Novavax’s COVID-19 vaccine 96.4 per cent effective against virus in phase-3 trial
New York: US-based biotech company Novavax's COVID-19 vaccine was 96.4 per cent effective against original strain of the virus in ...
Read moreDetails
New York: US-based biotech company Novavax's COVID-19 vaccine was 96.4 per cent effective against original strain of the virus in ...
Read moreDetails
The BJP-led NDA government’s proposed change in the nomenclature of the Centre’s flagship social welfare scheme for the poor, the...
Read moreDetails
It is not a bad idea, it appears, if top-notch politicians get incarcerated, at least for some days, so as...
Read moreDetails
The United States on 11 December unveiled a new strategic initiative ‘Pax Silica’ aimed at building a secure and trusted...
Read moreDetails
Governance is hard and good governance, meaning efficient and effective governance, is harder. Optics is a poor substitute for outcomes,...
Read moreDetails